CHEBI:16117 - β-D-galactosyl-(1→3)-N-acetyl-α-D-galactosaminyl group

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name β-D-galactosyl-(1→3)-N-acetyl-α-D-galactosaminyl group
ChEBI ID CHEBI:16117
ChEBI ASCII Name beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-galactosaminyl group
Definition An N-acetyl-D-galactosaminyl group in which D-Gal is linked β(1→3) to the D-GalNAc group which has α-configuration at its anomeric centre.
Stars This entity has been manually annotated by the ChEBI Team.
Secondary ChEBI IDs CHEBI:10387, CHEBI:12361, CHEBI:22785
Download Molfile XML SDF
Formula C14H24NO10
Net Charge 0
Average Mass 366.34110
Monoisotopic Mass 366.14002
SMILES [C@@H]1([C@H](O[C@@H]([C@@H]([C@@H]1O[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O)O)CO)*)NC(=O)C
Roles Classification
Biological Role(s): epitope
The biological role played by a material entity when bound by a receptor of the adaptive immune system. Specific site on an antigen to which an antibody binds.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing β-D-galactosyl-(1→3)-N-acetyl-α-D-galactosaminyl group (CHEBI:16117) has role epitope (CHEBI:53000)
β-D-galactosyl-(1→3)-N-acetyl-α-D-galactosaminyl group (CHEBI:16117) is a N-acetyl-D-galactosaminyl group (CHEBI:21507)
β-D-galactosyl-(1→3)-N-acetyl-α-D-galactosaminyl group (CHEBI:16117) is substituent group from β-D-Gal-(1→3)-α-D-GalNAc (CHEBI:61820)
IUPAC Name
β-D-galactopyranosyl-(1→3)-2-acetamido-2-deoxy-α-D-galactopyranosyl
Synonyms Sources
2-acetamido-2-deoxy-3-O-β-D-galactopyranosyl-α-D-galactopyranosyl JCBN
β-D-Gal-(1→3)-α-D-GalNAc-yl group ChEBI
β-D-galactosyl-(1→3)-N-acetyl-α-D-galactosaminyl ChEBI
β-D-galactosyl-(1→3)-N-acetyl-α-D-galactosaminyl group UniProt
β-D-galactosyl-1,3-N-acetyl-α-D-galactosaminyl group ChEBI
beta-D-Galactosyl-1,3-N-acetyl-alpha-D-galactosaminyl-R KEGG COMPOUND
β-Gal-(1→3)-α-GalNAc-R ChEBI
Gal-(β1,3)-GalNAc- ChEBI
Galβ1-3GalNAcα- ChEBI
Manual Xrefs Databases
C04750 KEGG COMPOUND
G00024 KEGG GLYCAN
View more database links
Citations Waiting for Citations
Last Modified
25 January 2022